Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Effectiveness of pneumococcal Haemophilus influenzae protein D conjugate vaccine against pneumonia in children: A cluster-randomised trial.

Kilpi TM, Jokinen J, Puumalainen T, Nieminen H, Ruokokoski E, Rinta-Kokko H, Traskine M, Lommel P, Moreira M, Ruiz-Guinazu J, Borys D, Schuerman L, Palmu AA.

Vaccine. 2018 Sep 18;36(39):5891-5901. doi: 10.1016/j.vaccine.2018.08.020. Epub 2018 Aug 23.

2.

Vaccine-preventable disease incidence of pneumococcal conjugate vaccine in the Finnish invasive pneumococcal disease vaccine trial.

Palmu AA, Jokinen J, Nieminen H, Rinta-Kokko H, Ruokokoski E, Puumalainen T, Moreira M, Schuerman L, Borys D, Kilpi TM.

Vaccine. 2018 Mar 27;36(14):1816-1822. doi: 10.1016/j.vaccine.2018.02.088.

3.

Testing Pneumonia Vaccines in the Elderly: Determining a Case Definition for Pneumococcal Pneumonia in the Absence of a Gold Standard.

Jokinen J, Snellman M, Palmu AA, Saukkoriipi A, Verlant V, Pascal T, Devaster JM, Hausdorff WP, Kilpi TM.

Am J Epidemiol. 2018 Jun 1;187(6):1295-1302. doi: 10.1093/aje/kwx373.

4.

Direct and Indirect Effectiveness of the 10-Valent Pneumococcal Conjugate Vaccine Against Carriage in a Cluster Randomized Trial.

Palmu AA, Toropainen M, Kaijalainen T, Siira L, Lahdenkari M, Nieminen H, Syrjänen RK, Kilpi TM, Jokinen J.

Pediatr Infect Dis J. 2017 Dec;36(12):1193-1200. doi: 10.1097/INF.0000000000001705.

PMID:
28737627
5.

Impact of ten-valent pneumococcal conjugate vaccine on pneumonia in Finnish children in a nation-wide population-based study.

Palmu AA, Rinta-Kokko H, Nohynek H, Nuorti JP, Kilpi TM, Jokinen J.

PLoS One. 2017 Mar 1;12(3):e0172690. doi: 10.1371/journal.pone.0172690. eCollection 2017.

6.

Effectiveness of the Ten-valent Pneumococcal Conjugate Vaccine Against Tympanostomy Tube Placements in a Cluster-randomized Trial.

Palmu AA, Jokinen J, Nieminen H, Rinta-Kokko H, Ruokokoski E, Puumalainen T, Traskine M, Moreira M, Borys D, Schuerman L, Kilpi TM.

Pediatr Infect Dis J. 2015 Nov;34(11):1230-5. doi: 10.1097/INF.0000000000000857.

PMID:
26284652
7.

Pneumococcal Conjugate Vaccine and Clinically Suspected Invasive Pneumococcal Disease.

Palmu AA, Kilpi TM, Rinta-Kokko H, Nohynek H, Toropainen M, Nuorti JP, Jokinen J.

Pediatrics. 2015 Jul;136(1):e22-7. doi: 10.1542/peds.2015-0458. Epub 2015 Jun 15.

8.

Efficacy of the 7-Valent Pneumococcal Conjugate Vaccine Against Acute Otitis Media Caused by Serotype 6C Pneumococcus.

Palmu AA, Kaijalainen T, Jokinen J, Kilpi TM.

Pediatr Infect Dis J. 2015 Jul;34(7):796-7. doi: 10.1097/INF.0000000000000728.

PMID:
25886787
9.

Effect of antimicrobial use on pneumococcal diagnostic tests in elderly patients with community-acquired pneumonia.

Saukkoriipi A, Palmu AA, Jokinen J, Verlant V, Hausdorff WP, Kilpi TM.

Eur J Clin Microbiol Infect Dis. 2015 Apr;34(4):697-704. doi: 10.1007/s10096-014-2278-5. Epub 2014 Nov 21.

PMID:
25413924
10.

Effectiveness of pandemic and seasonal influenza vaccines in preventing laboratory-confirmed influenza in adults: a clinical cohort study during epidemic seasons 2009-2010 and 2010-2011 in Finland.

Syrjänen RK, Jokinen J, Ziegler T, Sundman J, Lahdenkari M, Julkunen I, Kilpi TM.

PLoS One. 2014 Sep 29;9(9):e108538. doi: 10.1371/journal.pone.0108538. eCollection 2014.

11.

Vaccine effectiveness of the pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against clinically suspected invasive pneumococcal disease: a cluster-randomised trial.

Palmu AA, Jokinen J, Nieminen H, Syrjänen R, Ruokokoski E, Puumalainen T, Moreira M, Schuerman L, Borys D, Kilpi TM.

Lancet Respir Med. 2014 Sep;2(9):717-27. doi: 10.1016/S2213-2600(14)70139-0. Epub 2014 Aug 7.

PMID:
25127244
12.

Incidence and etiology of community-acquired pneumonia in the elderly in a prospective population-based study.

Palmu AA, Saukkoriipi A, Snellman M, Jokinen J, Torkko P, Ziegler T, Kaijalainen T, Hausdorff WP, Verlant V, Kilpi TM.

Scand J Infect Dis. 2014 Apr;46(4):250-9. doi: 10.3109/00365548.2013.876509. Epub 2014 Jan 29.

PMID:
24475952
13.

Effect of pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) on outpatient antimicrobial purchases: a double-blind, cluster randomised phase 3-4 trial.

Palmu AA, Jokinen J, Nieminen H, Rinta-Kokko H, Ruokokoski E, Puumalainen T, Borys D, Lommel P, Traskine M, Moreira M, Schuerman L, Kilpi TM.

Lancet Infect Dis. 2014 Mar;14(3):205-12. doi: 10.1016/S1473-3099(13)70338-4. Epub 2013 Nov 26.

PMID:
24287186
14.

Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: a cluster randomised trial.

Palmu AA, Jokinen J, Borys D, Nieminen H, Ruokokoski E, Siira L, Puumalainen T, Lommel P, Hezareh M, Moreira M, Schuerman L, Kilpi TM.

Lancet. 2013 Jan 19;381(9862):214-22. doi: 10.1016/S0140-6736(12)61854-6. Epub 2012 Nov 16. Erratum in: Lancet. 2013 May 18;381(9879):1720. Erratum in: Lancet. 2015 May 30;385(9983):2152.

PMID:
23158882
15.

Nasopharyngeal carriage of Streptococcus pneumoniae and pneumococcal urine antigen test in healthy elderly subjects.

Palmu AA, Kaijalainen T, Saukkoriipi A, Leinonen M, Kilpi TM.

Scand J Infect Dis. 2012 Jun;44(6):433-8. doi: 10.3109/00365548.2011.652162. Epub 2012 Jan 21.

PMID:
22263905
16.

Presence of capsular locus genes in immunochemically identified encapsulated and unencapsulated Streptococcus pneumoniae sputum isolates obtained from elderly patients with acute lower respiratory tract infection.

Kurola P, Erkkilä L, Kaijalainen T, Palmu AA, Hausdorff WP, Poolman J, Jokinen J, Kilpi TM, Leinonen M, Saukkoriipi A.

J Med Microbiol. 2010 Oct;59(Pt 10):1140-5. doi: 10.1099/jmm.0.016956-0. Epub 2010 Jul 8.

PMID:
20616188
17.

Pneumococcal carriage and acute otitis media induce serum antibodies to pneumococcal surface proteins CbpA and PhtD in children.

Simell B, Ahokas P, Lahdenkari M, Poolman J, Henckaerts I, Kilpi TM, Käyhty H.

Vaccine. 2009 Jul 23;27(34):4615-21. doi: 10.1016/j.vaccine.2009.05.071. Epub 2009 Jun 12.

PMID:
19524618
18.

Efficacy of pneumococcal conjugate vaccine against PCR-positive acute otitis media.

Palmu AA, Saukkoriipi A, Jokinen J, Leinonen M, Kilpi TM.

Vaccine. 2009 Mar 4;27(10):1490-1. doi: 10.1016/j.vaccine.2009.01.004. Epub 2009 Jan 23.

PMID:
19168111
19.

Development of antibodies to PspA families 1 and 2 in children after exposure to Streptococcus pneumoniae.

Melin MM, Hollingshead SK, Briles DE, Lahdenkari MI, Kilpi TM, Käyhty HM.

Clin Vaccine Immunol. 2008 Oct;15(10):1529-35. doi: 10.1128/CVI.00181-08. Epub 2008 Aug 27.

20.

Distribution of pneumococcal surface protein A families 1 and 2 among Streptococcus pneumoniae isolates from children in finland who had acute otitis media or were nasopharyngeal carriers.

Melin MM, Hollingshead SK, Briles DE, Hanage WP, Lahdenkari M, Kaijalainen T, Kilpi TM, Käyhty HM.

Clin Vaccine Immunol. 2008 Oct;15(10):1555-63. doi: 10.1128/CVI.00177-08. Epub 2008 Aug 27.

21.

Immunogenicity and reactogenicity of two diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio virus-Haemophilus influenzae type b vaccines administered at 3, 5 and 11-12 months of age.

Kilpi TM, Silfverdal SA, Nilsson L, Syrjänen R, Belloni C, Desole M, Triban C, Storsaeter J, Soila M, Jacquet JM.

Hum Vaccin. 2009 Jan-Feb;5(1):18-25. Epub 2009 Jan 2.

PMID:
18690013
22.

Antibodies to pneumococcal surface protein A families 1 and 2 in serum and saliva of children and the risk of pneumococcal acute otitis media.

Simell B, Melin M, Lahdenkari M, Briles DE, Hollingshead SK, Kilpi TM, Kayhty H.

J Infect Dis. 2007 Nov 15;196(10):1528-36. Epub 2007 Oct 31. Erratum in: J Infect Dis. 2008 Mar 1;197(5):779-80.

PMID:
18008233
23.

The value of nasopharyngeal culture in predicting the etiology of acute otitis media in children less than two years of age.

Syrjänen RK, Herva EE, Mäkelä PH, Puhakka HJ, Auranen KJ, Takala AK, Kilpi TM.

Pediatr Infect Dis J. 2006 Nov;25(11):1032-6.

PMID:
17072126
24.

Serum antibodies to pneumococcal neuraminidase NanA in relation to pneumococcal carriage and acute otitis media.

Simell B, Jaakkola T, Lahdenkari M, Briles D, Hollingshead S, Kilpi TM, Käyhty H.

Clin Vaccine Immunol. 2006 Oct;13(10):1177-9. Epub 2006 Aug 23.

25.

Pneumococcal acute otitis media in relation to pneumococcal nasopharyngeal carriage.

Syrjänen RK, Auranen KJ, Leino TM, Kilpi TM, Mäkelä PH.

Pediatr Infect Dis J. 2005 Sep;24(9):801-6.

PMID:
16148847
26.

Association of clinical signs and symptoms with pneumococcal acute otitis media by serotype--implications for vaccine effect.

Palmu AA, Jokinen JT, Kaijalainen T, Leinonen M, Karma P, Kilpi TM.

Clin Infect Dis. 2005 Jan 1;40(1):52-7. Epub 2004 Dec 6.

PMID:
15614692
27.

The seven-valent pneumococcal conjugate vaccine reduces tympanostomy tube placement in children.

Palmu AA, Verho J, Jokinen J, Karma P, Kilpi TM.

Pediatr Infect Dis J. 2004 Aug;23(8):732-8.

PMID:
15295223
28.

Concentration of antipneumococcal antibodies as a serological correlate of protection: an application to acute otitis media.

Jokinen JT, Ahman H, Kilpi TM, Mäkelä PH, Käyhty MH.

J Infect Dis. 2004 Aug 1;190(3):545-50. Epub 2004 Jul 2.

PMID:
15243930
29.

Does the presence of pneumococcal DNA in middle-ear fluid indicate pneumococcal etiology in acute otitis media?

Palmu AA, Saukkoriipi PA, Lahdenkari MI, Kuisma LK, Makela PH, Kilpi TM, Leinonen M.

J Infect Dis. 2004 Mar 1;189(5):775-84. Epub 2004 Feb 16.

PMID:
14976593
30.

Association of clinical signs and symptoms with bacterial findings in acute otitis media.

Palmu AA, Herva E, Savolainen H, Karma P, Mäkelä PH, Kilpi TM.

Clin Infect Dis. 2004 Jan 15;38(2):234-42. Epub 2003 Dec 19.

PMID:
14699456
31.

Pneumococcal carriage and otitis media induce salivary antibodies to pneumococcal capsular polysaccharides in children.

Simell B, Kilpi TM, Käyhty H.

J Infect Dis. 2002 Oct 15;186(8):1106-14. Epub 2002 Sep 16.

PMID:
12355361
32.

Nasopharyngeal carriage of Streptococcus pneumoniae in Finnish children younger than 2 years old.

Syrjänen RK, Kilpi TM, Kaijalainen TH, Herva EE, Takala AK.

J Infect Dis. 2001 Aug 15;184(4):451-9. Epub 2001 Jul 6.

PMID:
11471103
33.

Pneumococcal carriage and otitis media induce salivary antibodies to pneumococcal surface adhesin a, pneumolysin, and pneumococcal surface protein a in children.

Simell B, Korkeila M, Pursiainen H, Kilpi TM, Käyhty H.

J Infect Dis. 2001 Mar 15;183(6):887-96. Epub 2001 Feb 21.

PMID:
11237805
34.

Natural development of antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A, and pneumolysin in relation to pneumococcal carriage and acute otitis media.

Rapola S, Jäntti V, Haikala R, Syrjänen R, Carlone GM, Sampson JS, Briles DE, Paton JC, Takala AK, Kilpi TM, Käyhty H.

J Infect Dis. 2000 Oct;182(4):1146-52. Epub 2000 Sep 5.

PMID:
10979911
35.

Clinical evaluation of new pneumococcal vaccines: the Finnish approach.

Eskola J, Takala AK, Kilpi TM, Lankinen KS, Käyhty H.

Dev Biol Stand. 1998;95:85-92. Review.

PMID:
9855418

Supplemental Content

Loading ...
Support Center